News
SXTC
--
0.00%
--
NASDAQ Granted China SXT Pharmaceuticals, Inc. 180-Day Extension to Regain Compliance with Bid Price Requirement
China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), including Advanced TCMPs (Directly-Oral
PR Newswire · 09/09 14:00
China SXT Pharmaceuticals granted 180-day extension to regain compliance with Nasdaq
China SXT Pharmaceuticals (SXTC) is up 12.7% in pre-market, after being granted additional 180-day period, or until March 8, 2021, to regain compliance with NASDAQ's minimum $1.00 bid price per share requirement.The
Seekingalpha · 09/09 13:23
The Daily Biotech Pulse: Sanofi, GSK Begin Phase 1/2 Coronavirus Vaccine Study, Fulgent Strikes COVID-19 Testing Deal, New Data From Novavax
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2)
Benzinga · 09/03 11:55
The Daily Biotech Pulse: Amarin's Vascepa Appeal Hearing, Avid Bioservices' Strong Q1, A Life Sciences Blank Check IPO
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1)
Benzinga · 09/02 11:25
The Daily Biotech Pulse: Sanofi, Regeneron Drop COVID-19 Study, 2 Positive AstraZeneca Catalysts, Brickell Awarded Japanese Patent
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31)
Benzinga · 09/01 12:35
Hedge Funds Warming Up To China SXT Pharmaceuticals, Inc. (SXTC)
Insider Monkey · 05/29 20:08
The Daily Biotech Pulse: Sanofi, Regeneron Finalize Praluent Restructuring, Natus Pre-Announces Q1 Shortfall, Alcon To Delay Dividend Initiation
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs April 6.)
Benzinga · 04/07 11:57
The Daily Biotech Pulse: Fate Therapeutics Inks Cell Therapy Deal With J&J, Zentalis IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 2) BELLUS Health Inc (NASDAQ: BLU)
Benzinga · 04/03 11:36
China SXT Pharmaceuticals, Inc. Announces That It Received a Grant Supported by City Government
PR Newswire · 03/16 14:00
China SXT Pharma Reports Receives Grant Supported By City Gov't To Advance Directly-Oral Traditional Chinese Medicine Pieces Derived From Ag, No Terms Disclosed
Benzinga · 03/16 13:17
NVAX, SGMO among premarket gainers
Seeking Alpha - Article · 02/28 14:20
NEWR, SNAP among premarket losers
Seeking Alpha - Article · 02/05 14:19
I, LJPC, MFGP and AEMD among midday movers
Seeking Alpha - Article · 02/04 17:39
Healthcare stocks among major premarket losers
Seeking Alpha - Article · 02/04 14:13
How Does China SXT Pharmaceuticals's (NASDAQ:SXTC) P/E Compare To Its Industry, After Its Big Share Price Gain?
Simply Wall St. · 01/28 14:35
China SXT Pharmaceuticals, Inc. Announces Plans to Increase Production
Business Wire · 01/24 19:23
China SXT Pharmaceuticals, Inc. Announced Regulatory Approval of Its DNA Exam Laboratory
PR Newswire · 01/16 13:00
China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency
PR Newswire · 01/03 15:30
The Daily Biotech Pulse: Axovant Surges On Gene Therapy Study Results, FDA Approves Merck's Ebola Vaccine, Abeona Announces Offering
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Dec. 19.)
Benzinga · 12/20/2019 13:12
The Daily Biotech Pulse: Positive Adcom Verdict For Merck, Homology Medicine Slips On Mixed Gene Therapy Efficacy Data
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 17)
Benzinga · 12/18/2019 12:23
Webull provides a variety of real-time SXTC stock news. You can receive the latest news about CHINA SXT PHARMACEUTICALS, INC. through multiple platforms. This information may help you make smarter investment decisions.
About SXTC
China SXT Pharmaceuticals Inc is a China-based innovative pharmaceutical company that focuses on the research, development, manufacture, marketing and sales of Traditional Chinese Medicine Pieces (TCMP). The Company develops, manufactures and sells three types of TCMP products: advanced TCMP, fine TCMP and regular TCMP. The Company sells its TCMP products under three brand names such as Suxuangtang, Hui Chun Tang and Tong Ren Tang. As of November 5, 2019, the Company had a product portfolio of 19 advanced TCMPs, 20 Fine TCMPs and 427 Regular TCMPs that address a wide variety of diseases and medical indications.
More